Article Details

A San Diego startup sees covalent biologics as the next frontier in cancer drugs

Retrieved on: 2022-12-15 16:00:04

Tags for this article:

Click the tags to see associated articles and topics

A San Diego startup sees covalent biologics as the next frontier in cancer drugs. View article details on hiswai:

Excerpt

based company has the backing of several heavyweight investors including Avalon Ventures, Lightspeed Venture Partners, Frazier Life Sciences and ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up